Citation: | LIU Wanwan, ZHANG Shengyu, YANG Yu, ZHU Hongyan. Preparation of tumor-targeting chitosan micelle with transmembrane effect[J]. Journal of China Pharmaceutical University, 2015, 46(5): 561-567. DOI: 10.11665/j.issn.1000-5048.20150508 |
[1] |
Brijesh KS,Sirohi R,Archana D,et al.Porous chitosan scaffolds:a systematic study for choice of crosslinker and growth factor incorporation[J].Int J Polymer Mater,2015,5(64):242-252.
|
[2] |
Zhang L,Zhang N.Advances of chitosan and its derivatives in drug delivery system[J].Chin J New Drugs Clin Rem(中国新药与临床志),2014,33(1):9-14.
|
[3] |
Hu HY,Zhu H.Adsorption of heavy metal ions by chitosan and its derivatives[J].Prog Chem(化学进展),2012,24(11):2212-2223.
|
[4] |
Li SW,Tian JM,Jin J,et al.Targeted biodistribution of aminoglucose-modified doxorubicin.[J].J China Pharm Univ(中国药科大学学报),2012,43(3):266-270.
|
[5] |
Nijsten MW,van Dam GM.Hypothesis:using the Warburg effect against cancer by reducing glucose and providing lactate[J].Med Hypotheses,2009,73(1):48-51.
|
[6] |
Ganapathy V,Thangaraju M,Prasad PD.Nutrient transporters in cancer:relevance to Warburg hypothesis and beyond[J].Pharmacol Ther,2009,121(1):29-40.
|
[7] |
Chen J,Chen HY,Cui SS,et al.Glucosamine derivative modified nano structured lipid carriers for targeted tumor delivery[J].J Mater Chem,2012,22:5770-5783.
|
[8] |
Lindgren M,Hällbrink M,Prochiantz A,et al.Cell-penetrating peptides[J].Trends Pharmacol Sci,2000,21(3):99-103.
|
[9] |
Meloni BP,Milani D,Edwards AB,et al.Neuroprotective peptides fused to arginine-rich cell penetrating peptides:neuroprotective mechanism likely mediated by peptide endocytic properties[J].Pharmacol Ther,2015,153:36-54.
|
[10] |
Yin HQ,Zhang YH,Wang H,et al.The expression of fusion protein Myc-R9-EGFP and identification of its transmembrane ability[J].Biomed Eng(生物医学工程学杂志),2012,29(3):508-513.
|
[11] |
Wei YF.The application of cell-penetrating peptide in algae cells transduing allogenic material[D].Shandong:Graduate School of Chinese Academy of Sciences(Marine Research Institute):2014.
|
[12] |
Zhang N,Bai Y,Zhao JZ,et al.Preparation and penetrating effect of the polyarginine enhanced green fluorescence protein fusion protein[J].Chi J Biotechnol(生物工程学报),2013,29(11):1644-1653.
|
[13] |
Nagahara H,Vocero-Akbani AM,Snyder EL,et al.Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27 Kip1 induces cell migration[J].Nat Med,1998,4(12):1449-1452.
|
[14] |
Giacomelli C,Schmidt V,Borsali R.Nanocontainers formed by self-assembly of poly(ethylene oxide)-b-poly(glycerol monomethacrylate)-drug conjugates[J].Macromolecules,2007,40:2148-2157.
|
[15] |
Morita T,Horikiri Y,Suzuki T,et al.Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol):characterization and application to entrapment into biodegradable microspheres[J].Int J Pharm,2001,219(1/2):127-137.
|
[16] |
Ding Y,Wang Y,Opoku-Damoah Y,et al.Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy[J].Biomaterials,2015,72:90-103.
|
[17] |
Shan L,Liu M,Wu C,et al.Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy[J].Int J Nanomed,2015,10:5571-5591.
|
[1] | YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002 |
[2] | QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM2.5 suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408 |
[3] | LI Xiaoshi, WU Xunxun, ZHENG Zuguo, YANG Hua, LI Ping. Advances of long noncoding RNAs in myocardial fibrosis[J]. Journal of China Pharmaceutical University, 2020, 51(6): 646-654. DOI: 10.11665/j.issn.1000-5048.20200602 |
[4] | CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217 |
[5] | XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415 |
[6] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[7] | ZHAO Limeng, WANG Shuzhen. Therapeutic applications of small molecule kinase inhibitors in liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(2): 147-157. DOI: 10.11665/j.issn.1000-5048.20180203 |
[8] | XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112 |
[9] | DAI Li, ZHANG Lu, JI Hui, KONG Xiang-wen. Therapeutic effects of ZK14,a novel nitric oxide donating biphenyldicarboxylate derivative,on hepatic fibrosis in rats[J]. Journal of China Pharmaceutical University, 2009, 40(3): 254-257. |
[10] | Danshen Inhibiting Isoproterenol Induced Cardiac Hypertrophy and Fibrosis in Mice and its Mechanisms[J]. Journal of China Pharmaceutical University, 2003, (6): 84-87. |